Table 3. Correlation of miRNA expression with various aspects of prostate cancer (n=33).
Parameter | Tissue miRNA-182 expression | Tissue miRNA-187 expression | Urinary miRNA-182 expression | Urinary miRNA- 187 expression |
---|---|---|---|---|
Serum PSA | 0.953 | 0.002* | 0.678 | 0.157 |
Gleason Grade group | 0.841 | 0.567 | 0.879 | 0.721 |
D’Amico Risk stratification | 0.547 | 0.066 | 0.547 | 0.212 |
Metastasis on bone scan | 0.130 | <0.001* | 0.800 | 0.879 |
PSA = Prostate Specific Antigen; p-value calculated using Wilcoxon-rank sum test or Kruskal-Wallis test as appropriate; * p<0.05 considered as significant